News
Investing.com -- The American College of Cardiology released new recommendations on Friday stating that millions more ...
The U.S. trade deficit with Ireland has surged as $36 billion in hormone shipments for weight-loss and diabetes drugs were flown in to meet demand and avoid tariffs.
Treatments designed to help patients preserve muscle while losing weight with popular obesity drugs by Eli Lilly and Novo ...
Millions more Americans should be taking weight-loss drugs to prevent heart disease, according to the American College of ...
A radical shifting of trade flows has given Ireland the second-biggest trade imbalance with the U.S. after China, mostly due to demand for weight-loss drugs.
If you’re considering using medication to reach a healthy body weight, your first question might be: Are weight loss drugs covered by insurance? The short answer: Sometimes, but not always.
For patients with obesity, clinicians should move beyond a "try and fail" approach to lifestyle interventions and prioritize ...
Gone are the days of battling obesity with a limited toolbox. With more weight loss supplements and drugs on the market than ever before, deciding which medication is right for you isn' ...
Top Alternatives to Ozempic That Are EffectiveReviewed by Dr. Craig Primack, MD, FACP, FAAP, FOMAOzempic is a medication ...
A new study reports that people taking GLP-1 drugs in daily life don’t lose as much weight as those in clinical trials who ...
GLP-1 drugs are revolutionizing the treatment of obesity and diabetes. Here's what to know about investing in GLP-1 stocks.
A new obesity drug combining four hormones may outperform Wegovy and Mounjaro. Learn what it means for health, science, and investors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results